id	sid	eid	entity	type
ajlm-1841	1	1	cailin nieuwenhuizen department of haematology	ORG
ajlm-1841	1	2	university of pretoria	ORG
ajlm-1841	1	3	pretoria	GPE
ajlm-1841	1	4	south africa	GPE
ajlm-1841	1	5	national health laboratory service	ORG
ajlm-1841	1	6	pretoria	GPE
ajlm-1841	1	7	south africa	GPE
ajlm-1841	1	8	university of pretoria	ORG
ajlm-1841	1	9	pretoria	GPE
ajlm-1841	1	10	south africa	GPE
ajlm-1841	1	11	national health laboratory service	ORG
ajlm-1841	1	12	pretoria	GPE
ajlm-1841	1	13	south africa	GPE
ajlm-1841	1	14	johan potgieter	PERSON
ajlm-1841	1	15	university of pretoria	ORG
ajlm-1841	1	16	pretoria	GPE
ajlm-1841	1	17	south africa	GPE
ajlm-1841	1	18	national health laboratory service	ORG
ajlm-1841	1	19	pretoria	GPE
ajlm-1841	1	20	south africa	GPE
ajlm-1841	1	21	nieuwenhuizen c	ORG
ajlm-1841	1	22	potgieter j. establishment	PERSON
ajlm-1841	1	23	pretoria	GPE
ajlm-1841	1	24	south africa	GPE
ajlm-1841	1	25	secondary	ORDINAL
ajlm-1841	2	1	afr j	PERSON
ajlm-1841	3	1	2022;11(1	CARDINAL
ajlm-1841	4	1	pretoria	GPE
ajlm-1841	4	2	south africa	GPE
ajlm-1841	4	3	secondary	ORDINAL
ajlm-1841	4	4	cailin nieuwenhuizen	ORG
ajlm-1841	4	5	tshiphiri netshidzivhani	PERSON
ajlm-1841	4	6	johan potgieter	PERSON
ajlm-1841	4	7	28	CARDINAL
ajlm-1841	4	8	2022	CARDINAL
ajlm-1841	4	9	20	CARDINAL
ajlm-1841	4	10	2022	CARDINAL
ajlm-1841	4	11	12	CARDINAL
ajlm-1841	5	1	2022	CARDINAL
ajlm-1841	5	2	2022	CARDINAL
ajlm-1841	9	1	one	CARDINAL
ajlm-1841	11	1	south africa	GPE
ajlm-1841	13	1	the national health laboratory service haematology	ORG
ajlm-1841	13	2	pretoria	GPE
ajlm-1841	13	3	south africa	GPE
ajlm-1841	14	1	01 october 2012 to	DATE
ajlm-1841	14	2	31	CARDINAL
ajlm-1841	14	3	december 2020	DATE
ajlm-1841	14	4	144	CARDINAL
ajlm-1841	15	1	95%	PERCENT
ajlm-1841	17	1	40 years	DATE
ajlm-1841	17	2	3–84 years	DATE
ajlm-1841	18	1	2.3%	PERCENT
ajlm-1841	18	2	3.6%	PERCENT
ajlm-1841	19	1	2.3%	PERCENT
ajlm-1841	19	2	3.9%	PERCENT
ajlm-1841	19	3	2.95%	PERCENT
ajlm-1841	19	4	0.357%	PERCENT
ajlm-1841	22	1	haemoglobin a2	PERSON
ajlm-1841	25	1	80%	PERCENT
ajlm-1841	26	1	hba2	GPE
ajlm-1841	26	2	hba2	GPE
ajlm-1841	27	1	1.5%	PERCENT
ajlm-1841	27	2	approximately 80–90 million	CARDINAL
ajlm-1841	27	3	africa	LOC
ajlm-1841	27	4	1520	CARDINAL
ajlm-1841	27	5	annually	DATE
ajlm-1841	27	6	western africa	GPE
ajlm-1841	27	7	120	CARDINAL
ajlm-1841	28	1	120	CARDINAL
ajlm-1841	28	2	only 20	CARDINAL
ajlm-1841	28	3	hba2	GPE
ajlm-1841	29	1	hba2	GPE
ajlm-1841	29	2	hba2	GPE
ajlm-1841	29	3	hba2	GPE
ajlm-1841	30	1	africa	LOC
ajlm-1841	30	2	hba2	GPE
ajlm-1841	31	1	hba2	GPE
ajlm-1841	31	2	african	NORP
ajlm-1841	31	3	the national health laboratory service	ORG
ajlm-1841	31	4	pretoria	GPE
ajlm-1841	31	5	south africa	GPE
ajlm-1841	34	1	hba2	GPE
ajlm-1841	36	1	health sciences research ethics committee	ORG
ajlm-1841	36	2	the university of pretoria	ORG
ajlm-1841	42	1	01 october 2012 to	DATE
ajlm-1841	42	2	31	CARDINAL
ajlm-1841	42	3	december 2020	DATE
ajlm-1841	42	4	1	CARDINAL
ajlm-1841	44	1	two years	DATE
ajlm-1841	44	2	12.5	CARDINAL
ajlm-1841	44	3	75 fl	QUANTITY
ajlm-1841	44	4	100	CARDINAL
ajlm-1841	44	5	27	CARDINAL
ajlm-1841	44	6	15%	PERCENT
ajlm-1841	46	1	120	CARDINAL
ajlm-1841	46	2	1	CARDINAL
ajlm-1841	46	3	pretoria	GPE
ajlm-1841	46	4	south africa	GPE
ajlm-1841	46	5	01	CARDINAL
ajlm-1841	46	6	october 2012	DATE
ajlm-1841	46	7	31	CARDINAL
ajlm-1841	46	8	december 2020	DATE
ajlm-1841	47	1	a week	DATE
ajlm-1841	49	1	hba2	GPE
ajlm-1841	49	2	bio-rad®	ORG
ajlm-1841	49	3	hercules	GPE
ajlm-1841	49	4	california	GPE
ajlm-1841	49	5	united states	GPE
ajlm-1841	52	1	the south african national accreditation system	ORG
ajlm-1841	54	1	1	CARDINAL
ajlm-1841	54	2	bio-rad laboratories	ORG
ajlm-1841	54	3	irvine	GPE
ajlm-1841	54	4	california	GPE
ajlm-1841	54	5	united states	GPE
ajlm-1841	54	6	hba2	GPE
ajlm-1841	55	1	bio-rad®	ORG
ajlm-1841	55	2	hercules	GPE
ajlm-1841	55	3	california	GPE
ajlm-1841	55	4	united states	GPE
ajlm-1841	56	1	microsoft	ORG
ajlm-1841	56	2	microsoft corporation	ORG
ajlm-1841	56	3	redmond	GPE
ajlm-1841	56	4	washington	GPE
ajlm-1841	56	5	united states	GPE
ajlm-1841	57	1	144	CARDINAL
ajlm-1841	57	2	hba2	GPE
ajlm-1841	58	1	95%	PERCENT
ajlm-1841	58	2	2.5th	LAW
ajlm-1841	58	3	97.5th	CARDINAL
ajlm-1841	58	4	hba2	GPE
ajlm-1841	59	1	two	CARDINAL
ajlm-1841	60	1	pearson	PERSON
ajlm-1841	60	2	hba2	GPE
ajlm-1841	61	1	5%	PERCENT
ajlm-1841	62	1	15	CARDINAL
ajlm-1841	62	2	statacorp	ORG
ajlm-1841	62	3	texas	GPE
ajlm-1841	62	4	united states	GPE
ajlm-1841	63	1	144	CARDINAL
ajlm-1841	63	2	40 years	DATE
ajlm-1841	64	1	67	CARDINAL
ajlm-1841	64	2	77	CARDINAL
ajlm-1841	65	1	4.3%	PERCENT
ajlm-1841	65	2	hba2	PERSON
ajlm-1841	65	3	2.95%	PERCENT
ajlm-1841	65	4	between 2.2% and 3.9%	PERCENT
ajlm-1841	66	1	0.357%	PERCENT
ajlm-1841	66	2	2	CARDINAL
ajlm-1841	67	1	2	CARDINAL
ajlm-1841	67	2	pretoria	GPE
ajlm-1841	67	3	south africa	GPE
ajlm-1841	67	4	01	CARDINAL
ajlm-1841	67	5	october 2012	DATE
ajlm-1841	67	6	31	CARDINAL
ajlm-1841	67	7	december 2020	DATE
ajlm-1841	68	1	3	CARDINAL
ajlm-1841	69	1	hba2	GPE
ajlm-1841	69	2	2.3%	PERCENT
ajlm-1841	69	3	3.6%	PERCENT
ajlm-1841	70	1	3	CARDINAL
ajlm-1841	70	2	pretoria	GPE
ajlm-1841	70	3	south africa	GPE
ajlm-1841	70	4	01	CARDINAL
ajlm-1841	70	5	october 2012	DATE
ajlm-1841	70	6	31	CARDINAL
ajlm-1841	70	7	2020	DATE
ajlm-1841	71	1	hba2	PERSON
ajlm-1841	72	1	0.1328	MONEY
ajlm-1841	73	1	hba2	GPE
ajlm-1841	74	1	hba2	GPE
ajlm-1841	74	2	4	CARDINAL
ajlm-1841	74	3	0.2826	CARDINAL
ajlm-1841	75	1	4	CARDINAL
ajlm-1841	75	2	haemoglobin a2	PERSON
ajlm-1841	75	3	pretoria	GPE
ajlm-1841	75	4	south africa	GPE
ajlm-1841	75	5	01	CARDINAL
ajlm-1841	75	6	october 2012	DATE
ajlm-1841	75	7	31	CARDINAL
ajlm-1841	75	8	december 2020	DATE
ajlm-1841	76	1	hba2	GPE
ajlm-1841	76	2	2.3%	PERCENT
ajlm-1841	76	3	3.6%	PERCENT
ajlm-1841	77	1	hba2	GPE
ajlm-1841	78	1	the leiden university	ORG
ajlm-1841	78	2	netherlands	GPE
ajlm-1841	78	3	bio-rad®	ORG
ajlm-1841	78	4	hba2	GPE
ajlm-1841	78	5	2.3%	PERCENT
ajlm-1841	78	6	3.5%.3	CARDINAL
ajlm-1841	78	7	the leiden group	ORG
ajlm-1841	78	8	bio-rad®	ORG
ajlm-1841	79	1	han et al	PERSON
ajlm-1841	79	2	2.3%	PERCENT
ajlm-1841	79	3	3.1%	PERCENT
ajlm-1841	79	4	hba2	GPE
ajlm-1841	79	5	chinese	NORP
ajlm-1841	79	6	capillarys2	PERSON
ajlm-1841	79	7	france	GPE
ajlm-1841	79	8	hba2	GPE
ajlm-1841	79	9	4%	PERCENT
ajlm-1841	79	10	almost 100%	PERCENT
ajlm-1841	79	11	90%	PERCENT
ajlm-1841	79	12	between 3.1	CARDINAL
ajlm-1841	79	13	3.9	CARDINAL
ajlm-1841	80	1	giambona et al	PERSON
ajlm-1841	80	2	80%	PERCENT
ajlm-1841	80	3	italian	NORP
ajlm-1841	80	4	hba2	GPE
ajlm-1841	80	5	3.5–3.9	CARDINAL
ajlm-1841	80	6	80	CARDINAL
ajlm-1841	82	1	hba2	GPE
ajlm-1841	83	1	hba2	GPE
ajlm-1841	83	2	70 years or older	DATE
ajlm-1841	84	1	2.3–3.6	CARDINAL
ajlm-1841	84	2	one	CARDINAL
ajlm-1841	90	1	4000	CARDINAL
ajlm-1841	91	1	population.17	LOC
ajlm-1841	91	2	katayev et al	ORG
ajlm-1841	92	1	eight	CARDINAL
ajlm-1841	93	1	one	CARDINAL
ajlm-1841	94	1	hba2	GPE
ajlm-1841	97	1	hba2	GPE
ajlm-1841	98	1	hba2	GPE
ajlm-1841	98	2	2.3%	PERCENT
ajlm-1841	98	3	3.6%	PERCENT
ajlm-1841	101	1	hba2	GPE
ajlm-1841	103	1	r. pool	PERSON
ajlm-1841	103	2	dr d. toi	PERSON
ajlm-1841	106	1	c.n.	PERSON
ajlm-1841	107	1	j.p.	PERSON
ajlm-1841	107	2	c.n.	GPE
ajlm-1841	108	1	j.p.	PERSON
ajlm-1841	110	1	the university of pretoria development fund	ORG
ajlm-1841	111	1	c.n.	GPE
ajlm-1841	115	1	jones g	PERSON
ajlm-1841	115	2	barker a.	PERSON
ajlm-1841	116	1	clin biochem rev	ORG
ajlm-1841	116	2	2008;29(suppl 1):s93	DATE
ajlm-1841	118	1	j clin	PERSON
ajlm-1841	119	1	2009;62(1):13–17	CARDINAL
ajlm-1841	120	1	stephens	PERSON
ajlm-1841	122	1	2012;34(1):1–13	ORG
ajlm-1841	123	1	origa r. beta-thalassemia	PERSON
ajlm-1841	125	1	2010;5(1):11	CARDINAL
ajlm-1841	126	1	modell b	ORG
ajlm-1841	126	2	darlison m. global	PERSON
ajlm-1841	127	1	bull world health	ORG
ajlm-1841	128	1	2008;86(6):480–487	TIME
ajlm-1841	128	2	katayev	GPE
ajlm-1841	128	3	seccombe dw	PERSON
ajlm-1841	130	1	j clin	PERSON
ajlm-1841	131	1	2010;133(2):180–186	CARDINAL
ajlm-1841	131	2	boyd j. defining	PERSON
ajlm-1841	133	1	wayne	PERSON
ajlm-1841	133	2	2010	DATE
ajlm-1841	134	1	han	NORP
ajlm-1841	134	2	huang l	PERSON
ajlm-1841	134	3	li yy	PERSON
ajlm-1841	134	4	hba2	GPE
ajlm-1841	134	5	hbf	ORG
ajlm-1841	134	6	hba2	GPE
ajlm-1841	134	7	guizhou	GPE
ajlm-1841	135	1	clin biochem	ORG
ajlm-1841	136	1	2019;65:24–28	DATE
ajlm-1841	137	1	greene dn	PERSON
ajlm-1841	137	2	vaughn cp	PERSON
ajlm-1841	137	3	agarwal am	PERSON
ajlm-1841	139	1	clin chim acta	PERSON
ajlm-1841	140	1	2015;439:50–57	CARDINAL
ajlm-1841	141	1	giambona	PERSON
ajlm-1841	141	2	maggio a.	PERSON
ajlm-1841	142	1	clin biochem	ORG
ajlm-1841	143	1	2009;42(18):1786–1796	CARDINAL
ajlm-1841	144	1	giambona	PERSON
ajlm-1841	144	2	italian	NORP
ajlm-1841	146	1	2008;93(9):1380–1384	CARDINAL
ajlm-1841	146	2	tamagnini gp	PERSON
ajlm-1841	146	3	gonçalves p	ORG
ajlm-1841	146	4	ribeiro ml	PERSON
ajlm-1841	147	1	portuguese	NORP
ajlm-1841	147	2	two	CARDINAL
ajlm-1841	149	1	1993;17(1):31–40	CARDINAL
ajlm-1841	149	2	dimovski aj	PERSON
ajlm-1841	149	3	baysal e	PERSON
ajlm-1841	151	1	british journal of haematology	ORG
ajlm-1841	152	1	1994;86(4):824–830	CARDINAL
ajlm-1841	153	1	bohn mk	PERSON
ajlm-1841	153	2	adeli k. application	PERSON
ajlm-1841	156	1	yang j	PERSON
ajlm-1841	156	2	li y, liu q	PERSON
ajlm-1841	157	1	j evid	PERSON
ajlm-1841	158	1	https://doi.org/10.1111/jebm.12373 katayev	PERSON
ajlm-1841	158	2	fleming jk	PERSON
ajlm-1841	158	3	fisher	PERSON
ajlm-1841	159	1	j clin	PERSON
ajlm-1841	160	1	2015;143(1):134–142	CARDINAL